Mucormycosis, Relaxation of Lockdown, Vaccination Rates: COVID-19 Global Weekly Highlights – Medscape

These are the global coronavirus stories you need to know about this week.
Doctors in India are reporting a sharp increase in cases of mucormycosis in patients recovering and recovered from COVID-19, particularly among those with diabetes. It is believed that suppressed immunity resulting from use of steroids for treating moderate and severe COVID-19 may trigger this rare but deadly fungal infection. 
In the UK, the alert level was reduced from 4 to 3 by the four UK CMOs. This means a COVID-19 epidemic…

Click here to view the original article.